TickerFacts.

Kyverna Therapeutics, Inc. (KYTX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

44.26M
Year ended 2025-12-31
2023-12-31: 673.6K2024-12-31: 38.33M2025-12-31: 44.26M44.26M
2023-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3144.26M+15.5%2026-03-26, From 2025-01-01
2024-12-3138.33Mn/m2026-03-26, From 2024-01-01
2023-12-31673.6Kn/a2025-03-27, From 2023-01-01